Close Menu

Takara Bio

NEW YORK (GenomeWeb News) — WaferGen Biosystems said today that it has completed a private placement of common stock, Series 1 convertible preferred stock, and warrants to purchase shares of common stock to accredited investors, netting just over $15 million.

NEW YORK (GenomeWeb News) – Wafergen Biosystems announced late on Tuesday a series of moves — including a stock split, a capital restructuring, and a private placement to raise up to roughly $17.3 million — to boost its share price and improve its cash position.

NEW YORK (GenomeWeb News) – WaferGen BioSystems said this week that its revenues for the second quarter rose 12-fold year over year.

Clontech Laboratories and Rubicon Genomics have launched the SMARTer Universal Low Input RNA Library Prep Kit.

NEW YORK (GenomeWeb News) – Clontech Laboratories and Rubicon Genomics today announced a partnership to integrate each other's technology for RNA sample preparation for next-generation sequencing applications.

Aviir has launched two comprehensive genetic panels to test for undiagnosed arrhythmia or cardiomyopathy. The tests cover the major causes of cardiomyopathies, arrhythmia disorders, and other genetically transmitted diseases that affect the heart and vasculature.

Life Technologies' Ion Torrent has launched new versions of its PGM chips that increase throughput.

NEW YORK (GenomeWeb News) – Invivoscribe Technologies today said that a German court has ruled in its favor in a patent dispute over FLT3 testing technology.

NEW YORK (GenomeWeb News) – WaferGen BioSystems said in a regulatory document that revenues for its first quarter more than doubled year over year.
It separately also announced a stock sale by shareholders of up to more than 112 million shares.

WaferGen Biosystems this week launched the SmartChip TE, a PCR-based target-enrichment product for sample preparation prior to targeted re-sequencing on next-generation platforms.

Pages

NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.

According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.

A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.

In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.